Cargando…
Recombinant human erythropoietin stimulates melanoma tumor growth through activation of initiation factor eIF4E
Recombinant human erythropoietin (EPO) is standard treatment for anemia in cancer patients. Recent clinical trials suggest that EPO may accelerate tumor progression and increase mortality. However, the evidence supporting a growth-promoting effect of EPO has remained controversial. Employing an in v...
Autores principales: | Julius, Annabelle, Desai, Anjali, Yung, Raymond L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5444745/ https://www.ncbi.nlm.nih.gov/pubmed/28415825 http://dx.doi.org/10.18632/oncotarget.16331 |
Ejemplares similares
-
eIF5 and eIF5B together stimulate 48S initiation complex formation during ribosomal scanning
por: Pisareva, Vera P., et al.
Publicado: (2014) -
eIF5 and eIF5B together stimulate 48S initiation complex formation during ribosomal scanning
Publicado: (2021) -
Molecular Architecture of the 40S⋅eIF1⋅eIF3 Translation Initiation Complex
por: Erzberger, Jan P., et al.
Publicado: (2014) -
Molecular Architecture of the 40S⋅eIF1⋅eIF3 Translation Initiation Complex
por: Erzberger, Jan P., et al.
Publicado: (2014) -
eIF4B, eIF4G and RNA regulate eIF4A activity in translation initiation by modulating the eIF4A conformational cycle
por: Harms, Ulf, et al.
Publicado: (2014)